SCHEMBL1667781

SCHEMBL1667781

C=CCc1ccccc1Nn1cnc2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.39
PKM P14618 4/20 0.39
KMT2A Q03164 4/20 0.39
MAPT P10636 4/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 2/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 2/20 0.38
HTT P42858 4/20 0.37
NPSR1 Q6W5P4 3/20 0.37
ALDH1A1 P00352 3/20 0.37
USP2 O75604 2/20 0.37
LMNA P02545 1/20 0.37
HIF1A Q16665 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8573937 0.73 TDP1 (0.41) MEN1KMT2AMAPTALOX15HSD17B10
SCHEMBL1062170 0.73 TDP1 (0.44) MEN1KMT2AMAPTALOX15HSD17B10
SCHEMBL239691 0.69 HTT (0.48) MEN1KMT2AMAPTALOX15HSD17B10
SCHEMBL9635435 0.69 HSD17B10 (0.49) MEN1KMT2AALOX15HSD17B10ALDH1A1
SCHEMBL176287 0.68 ADRA2C (0.47) MEN1KMT2AMAPTADRA2BADRA2C
SCHEMBL15022038 0.68 TDP1 (0.52) MEN1KMT2AALOX15HSD17B10TDP1
SCHEMBL7965647 0.66 ADRA2B (0.40) MEN1PKMKMT2AMAPTALOX15
SCHEMBL15540408 0.66 HTT (0.49) MEN1KMT2AMAPTTDP1CYP11B1
SCHEMBL7597344 0.65 HSD17B10 (0.54) MAPTALOX15HSD17B10NPSR1ALDH1A1
SCHEMBL11844044 0.65 ALOX15 (0.55) KMT2AMAPTALOX15HSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150183770-A1 5-RING HETEROAROMATIC COMPOUNDS AND THEIR USE AS BINDING PARTNERS FOR 5-HT5 RECEPTORS ABBVIE DEUTSCHLAND (DE) 2015-07-02 US disclosed
US-8921406-B2 5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors AbbVie Deutschland GmbH & Co. KG (DE) 2014-12-30 US disclosed
EP-1917251-B1 5-RING HETEROAROMATIC COMPOUNDS AND THEIR USE AS BINDING PARTNERS FOR 5-HT5 RECEPTORS ABBOTT GMBH & CO KG (DE) 2013-04-03 EP disclosed
US-20110207788-A1 5-Ring Heteroaromatic compounds and their use as binding partners for 5-ht5 receptors ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2011-08-25 US disclosed
EP-2308852-A1 5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors Abbott GmbH & Co. KG (DE) 2011-04-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150183770-A1 5-RING HETEROAROMATIC COMPOUNDS AND THEIR USE AS BINDING PARTNERS FOR 5-HT5 RECEPTORS HTR5A, HTR3A, HTR6 MEN1 2890/4885PKM 3299/4885KMT2A 4010/4885
US-20110207788-A1 5-Ring Heteroaromatic compounds and their use as binding partners for 5-ht5 receptors HTR5A, HTR3A, HTR6 MEN1 2890/4885PKM 3299/4885KMT2A 4010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.